Found 17 matching trials
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors PHASE2 RATIONALE: Drugs used in chemotherapy, such as capecitabine, streptozocin, ...
Show More Location
Basildon University Hospital
Learn More & Join Trial
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. PHASE2 This 2 arm study will assess the efficacy and safety of two systemic treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor PHASE3 The purpose of this study is to compare streptozotocin (STZ) vs everolimus ...
Show More Location
Aarhus Aarhus University Hospital NET Centre (AUH-NET)
Learn More & Join Trial
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) PHASE3 This study will compare the safety and efficacy of a three-day oral aprepit...
Show More Location
Multiple Locations
Learn More & Join Trial
Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer PHASE1 RATIONALE: Monoclonal antibodies can find and locate tumor cells and either...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Two Chemotherapy Regimens Plus or Minus Bevacizumab PHASE2 Compare the effect of capecitabine (cape) + temozolomide (temo) and of 5FU ...
Show More Status
Active Not Recruiting
Location
Centre Antoine Lacassagne
Learn More & Join Trial
MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents NA Neuroendocrine tumors (NET) are rare but their incidence is growing. Alkyla...
Show More Location
Hôpital Sud - CHU Amiens
Learn More & Join Trial
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors PHASE2 Open label, single-arm phase II study of avastin combined with fluorouracil...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia PHASE3 Sodium zirconium cyclosilicate has been shown to be effective and safe in a...
Show More Learn More & Join Trial